Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Merial Starts $70 Million China Animal Health Facility Expansion

publication date: Oct 12, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Merial, the animal health division of Sanofi-Aventis, broke ground on a $70 million expansion of its manufacturing facility in the Nanchang Hi-tech Development Zone. The existing factory, which has been in operation for almost 20 years, produces poultry vaccines for use in China. Phase I of the new construction will add almost 30,000 square meters of floor space, and the expansion will ultimately double the existing facility’s production capacity. More details...

Stock Symbol: (NYSE: SNY)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...